THE INTELLIS™ PLATFORM MOVING INNOVATION
FORWARD, TOGETHER

CLINICAL OUTCOMES: VECTORS STUDY
12-MONTH RESULTS Using the Evolve Workflow
SPINAL CORD STIMULATION

pain relief infographic
equipment

90% TRIAL SUCCESS RATE

with the EvolveSM workflow.1,2

OVERALL, BACK AND
LEG PAIN RELIEF

was significant and sustained
through 12 months.1,2

85% OF PATIENTS
WERE SATISFIED

with the therapy at 12 months.1,2

COMING BACK TO ME

Would you like to know more about the Intellis™ platform.

DOWNLOAD THE BROCHURE

The Intellis™ SCS Platform pushes the boundaries of SCS, combining the smallest neurostimulator with a suite of cutting-edge technologies, outcomes and services that redefine what clinicans and patients should expect from chronic pain management.

battery icon

OVERDRIVETM
BATTERY

What would your patients do with more free time?
Learn more 

 

surscan icon

SURESCANTM
MRI

Performs MRI scan in Normal Operating Mode up on every product in the portfolio
Learn more 

 

snapshot icon

SNAPSHOTTM
REPORTING

The opportunity to deliver meaningful patient outcomes with activity diaries
Learn more 

 

evolve icon

EVOLVESM
WORKFLOW

Offers standardized guidance to optimize patient therapy with HD and LD dosing options Learn more

 

 

All relevant therapy information, 
including the fluoroscopy image 
library and daily activity data, 
is stored on the Intellis™ device.

intellis
tablet

To download all of our information
on THE INTELLIS™ PLATFORM, fill in your details here:

*Indicates Required Field

Your information will be processed and protected in accordance with our privacy statement

View our privacy statement

*   Provides safe access to MRI scans anywhere on the body. Under specific conditions. refer to product labeling for full list of conditions.

1   J Hatheway, M Fishman, et al. Vectors Post Market Study: Pain relief outcomes using spinal cord stimulation with high dose stimulation parameters. Poster presentation at the North American Neuromodulation Society 23rd Annual Meeting, Jan. 2020, Las Vegas

2   T Weaver, M Fishman, et al. Vectors Post Market Study: Subject activity goals and satisfaction with spinal cord stimulation through 3 months. Poster presentation at the North American Neuromodulation Society 23rd Annual Meeting, Jan. 2020, Las Vegas